<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2018-01-31" version="227">
<accession>P00747</accession>
<accession>Q15146</accession>
<accession>Q5TEH4</accession>
<accession>Q6PA00</accession>
<name>PLMN_HUMAN</name>
<protein>
<recommendedName>
<fullName>Plasminogen</fullName>
<ecNumber>3.4.21.7</ecNumber>
</recommendedName>
<component>
<recommendedName>
<fullName>Plasmin heavy chain A</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Activation peptide</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Angiostatin</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Plasmin heavy chain A, short form</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Plasmin light chain B</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">PLG</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="6104" last="6111">
<title>Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system.</title>
<authorList>
<person name="Petersen T.E."/>
<person name="Martzen M.R."/>
<person name="Ichinose A."/>
<person name="Davie E.W."/>
</authorList>
<dbReference type="PubMed" id="2318848"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT ASN-472</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1987" name="FEBS Lett." volume="213" first="254" last="260">
<title>Molecular cloning and characterization of a full-length cDNA clone for human plasminogen.</title>
<authorList>
<person name="Forsgren M."/>
<person name="Raden B."/>
<person name="Israelsson M."/>
<person name="Larsson K."/>
<person name="Heden L.-O."/>
</authorList>
<dbReference type="PubMed" id="3030813"/>
<dbReference type="DOI" id="10.1016/0014-5793(87)81501-6"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="1991-10" db="EMBL/GenBank/DDBJ databases">
<title>Expression of recombinant human plasminogen and aglycoplasminogen in HeLa cells.</title>
<authorList>
<person name="Browne M.J."/>
<person name="Chapman C.G."/>
<person name="Dodd I."/>
<person name="Carey J.E."/>
<person name="Lawrence G.M.P."/>
<person name="Mitchell D."/>
<person name="Robinson J.H."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2002-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS LYS-57; GLN-133; HIS-261; TRP-408; ASN-472; VAL-494 AND TRP-523</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="Nature" volume="425" first="805" last="811">
<title>The DNA sequence and analysis of human chromosome 6.</title>
<authorList>
<person name="Mungall A.J."/>
<person name="Palmer S.A."/>
<person name="Sims S.K."/>
<person name="Edwards C.A."/>
<person name="Ashurst J.L."/>
<person name="Wilming L."/>
<person name="Jones M.C."/>
<person name="Horton R."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Gilbert J.G.R."/>
<person name="Clamp M.E."/>
<person name="Bethel G."/>
<person name="Milne S."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews T.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bray-Allen S."/>
<person name="Brook J."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clark G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Collins J.E."/>
<person name="Colman L.K."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Culley K.M."/>
<person name="Dhami P."/>
<person name="Davies J."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.E."/>
<person name="Evans K.A."/>
<person name="Faulkner L."/>
<person name="Francis M.D."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori M.J."/>
<person name="Gilby L.M."/>
<person name="Gillson C.J."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Grant M."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Hall R."/>
<person name="Halls K.S."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Heathcott R."/>
<person name="Holmes S.J."/>
<person name="Howden P.J."/>
<person name="Howe K.L."/>
<person name="Howell G.R."/>
<person name="Huckle E."/>
<person name="Humphray S.J."/>
<person name="Humphries M.D."/>
<person name="Hunt A.R."/>
<person name="Johnson C.M."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S.J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C.R."/>
<person name="Lloyd D.M."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Maslen G.L."/>
<person name="Matthews L."/>
<person name="McCann O.T."/>
<person name="McLaren S.J."/>
<person name="McLay K."/>
<person name="McMurray A."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Niblett D."/>
<person name="Nickerson T."/>
<person name="Novik K.L."/>
<person name="Oliver K."/>
<person name="Overton-Larty E.K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S."/>
<person name="Plumb R.W."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Ranby S.A."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Searle S.M."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Skuce C.D."/>
<person name="Smith S."/>
<person name="Smith M."/>
<person name="Spraggon L."/>
<person name="Squares S.L."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tamlyn-Hall G."/>
<person name="Tester J."/>
<person name="Theaker A.J."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="White S.S."/>
<person name="Whitehead S.L."/>
<person name="Whittaker H."/>
<person name="Wild A."/>
<person name="Willey D.J."/>
<person name="Wilmer T.E."/>
<person name="Wood J.M."/>
<person name="Wray P.W."/>
<person name="Wyatt J.C."/>
<person name="Young L."/>
<person name="Younger R.M."/>
<person name="Bentley D.R."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Dunham I."/>
<person name="Rogers J."/>
<person name="Beck S."/>
</authorList>
<dbReference type="PubMed" id="14574404"/>
<dbReference type="DOI" id="10.1038/nature02055"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT ASP-676</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="1977-07" db="PIR data bank">
<authorList>
<person name="Sottrup-Jensen L."/>
<person name="Petersen T.E."/>
<person name="Magnusson S."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 20-810</scope>
<scope>VARIANT ASN-472</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1975" name="Eur. J. Biochem." volume="50" first="489" last="494">
<title>Structural relationship between 'glutamic acid' and 'lysine' forms of human plasminogen and their interaction with the NH2-terminal activation peptide as studied by affinity chromatography.</title>
<authorList>
<person name="Wiman B."/>
<person name="Wallen P."/>
</authorList>
<dbReference type="PubMed" id="122932"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1975.tb09887.x"/>
</citation>
<scope>PROTEIN SEQUENCE OF 20-100</scope>
</reference>
<reference key="9">
<citation type="book" date="1978" name="Progress in chemical fibrinolysis and thrombolysis" volume="3" first="191" last="209" publisher="Raven Press" city="New York">
<title>The primary structure of human plasminogen.</title>
<editorList>
<person name="Davidson J.F."/>
<person name="Rowan R.M."/>
<person name="Samama M.M."/>
<person name="Desnoyers P.C."/>
</editorList>
<authorList>
<person name="Sottrup-Jensen L."/>
<person name="Claeys H."/>
<person name="Zajdel M."/>
<person name="Petersen T.E."/>
<person name="Magnusson S."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 95-580; 581-626; 657-700 AND 732-810</scope>
<scope>VARIANT ASN-472</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1984" name="Biochemistry" volume="23" first="4243" last="4250">
<title>Characterization of a complementary deoxyribonucleic acid coding for human and bovine plasminogen.</title>
<authorList>
<person name="Malinowski D.P."/>
<person name="Sadler J.E."/>
<person name="Davie E.W."/>
</authorList>
<dbReference type="PubMed" id="6148961"/>
<dbReference type="DOI" id="10.1021/bi00313a035"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 292-810</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1975" name="Eur. J. Biochem." volume="58" first="539" last="547">
<title>Amino-acid sequence of the cyanogen-bromide fragment from human plasminogen that forms the linkage between the plasmin chains.</title>
<authorList>
<person name="Wiman B."/>
<person name="Wallen P."/>
</authorList>
<dbReference type="PubMed" id="126863"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1975.tb02403.x"/>
</citation>
<scope>PROTEIN SEQUENCE OF 483-604</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1977" name="Eur. J. Biochem." volume="76" first="129" last="137">
<title>Primary structure of the B-chain of human plasmin.</title>
<authorList>
<person name="Wiman B."/>
</authorList>
<dbReference type="PubMed" id="142009"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1977.tb11578.x"/>
</citation>
<scope>PROTEIN SEQUENCE OF 581-810</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1973" name="J. Biol. Chem." volume="248" first="1631" last="1633">
<title>The primary structure of human plasminogen. II. The histidine loop of human plasmin: light (B) chain active center histidine sequence.</title>
<authorList>
<person name="Robbins K.C."/>
<person name="Bernabe P."/>
<person name="Arzadon L."/>
<person name="Summaria L."/>
</authorList>
<dbReference type="PubMed" id="4694729"/>
</citation>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1969" name="J. Biol. Chem." volume="244" first="3590" last="3597">
<title>Studies on the active center of human plasmin. Partial amino acid sequence of a peptide containing the active center serine residue.</title>
<authorList>
<person name="Groskopf W.R."/>
<person name="Summaria L."/>
<person name="Robbins K.C."/>
</authorList>
<dbReference type="PubMed" id="4240117"/>
</citation>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1982" name="J. Biol. Chem." volume="257" first="7401" last="7406">
<title>Structure of the omega-aminocarboxylic acid-binding sites of human plasminogen. Arginine 70 and aspartic acid 56 are essential for binding of ligand by kringle 4.</title>
<authorList>
<person name="Trexler M."/>
<person name="Vali Z."/>
<person name="Patthy L."/>
</authorList>
<dbReference type="PubMed" id="6919539"/>
</citation>
<scope>OMEGA-AMINOCARBOXYLIC ACID-BINDING SITES</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1984" name="J. Biol. Chem." volume="259" first="13690" last="13694">
<title>The fibrin-binding site of human plasminogen. Arginines 32 and 34 are essential for fibrin affinity of the kringle 1 domain.</title>
<authorList>
<person name="Vali Z."/>
<person name="Patthy L."/>
</authorList>
<dbReference type="PubMed" id="6094526"/>
</citation>
<scope>FIBRIN AND OMEGA-AMINOCARBOXYLIC ACID BINDING SITES</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1997" name="Biochemistry" volume="36" first="8100" last="8106">
<title>Serine-578 is a major phosphorylation locus in human plasma plasminogen.</title>
<authorList>
<person name="Wang H."/>
<person name="Prorok M."/>
<person name="Bretthauer R.K."/>
<person name="Castellino F.J."/>
</authorList>
<dbReference type="PubMed" id="9201958"/>
<dbReference type="DOI" id="10.1021/bi970328d"/>
</citation>
<scope>PHOSPHORYLATION AT SER-597</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1988" name="Eur. J. Biochem." volume="173" first="57" last="63">
<title>The N- and O-linked carbohydrate chains of human, bovine and porcine plasminogen. Species specificity in relation to sialylation and fucosylation patterns.</title>
<authorList>
<person name="Marti T."/>
<person name="Schaller J."/>
<person name="Rickli E.E."/>
<person name="Schmid K."/>
<person name="Kamerling J.P."/>
<person name="Gerwig G.J."/>
<person name="van Halbeek H."/>
<person name="Vliegenthart J.F.G."/>
</authorList>
<dbReference type="PubMed" id="3356193"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1988.tb13966.x"/>
</citation>
<scope>GLYCOSYLATION AT SER-268; ASN-308 AND THR-365</scope>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="5718" last="5726">
<title>Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-proline-rich glycoprotein.</title>
<authorList>
<person name="Borza D.B."/>
<person name="Morgan W.T."/>
</authorList>
<dbReference type="PubMed" id="9102401"/>
<dbReference type="DOI" id="10.1074/jbc.272.9.5718"/>
</citation>
<scope>INTERACTION WITH HRG</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="7408" last="7411">
<title>Evidence for a novel O-linked sialylated trisaccharide on Ser-248 of human plasminogen 2.</title>
<authorList>
<person name="Pirie-Shepherd S.R."/>
<person name="Stevens R.D."/>
<person name="Andon N.L."/>
<person name="Enghild J.J."/>
<person name="Pizzo S.V."/>
</authorList>
<dbReference type="PubMed" id="9054441"/>
<dbReference type="DOI" id="10.1074/jbc.272.11.7408"/>
</citation>
<scope>GLYCOSYLATION AT SER-268</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1994" name="Cell" volume="79" first="315" last="328">
<title>Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.</title>
<authorList>
<person name="O'Reilly M.S."/>
<person name="Holmgren L."/>
<person name="Shing Y."/>
<person name="Chen C."/>
<person name="Rosenthal R.A."/>
<person name="Moses M."/>
<person name="Lane W.S."/>
<person name="Cao Y."/>
<person name="Sage E.H."/>
<person name="Folkman J."/>
</authorList>
<dbReference type="PubMed" id="7525077"/>
<dbReference type="DOI" id="10.1016/0092-8674(94)90200-3"/>
</citation>
<scope>CHARACTERIZATION OF ANGIOSTATIN</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1997" name="Cancer Res." volume="57" first="1329" last="1334">
<title>A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.</title>
<authorList>
<person name="Sim B.K."/>
<person name="O'Reilly M.S."/>
<person name="Liang H."/>
<person name="Fortier A.H."/>
<person name="He W."/>
<person name="Madsen J.W."/>
<person name="Lapcevich R."/>
<person name="Nacy C.A."/>
</authorList>
<dbReference type="PubMed" id="9102221"/>
</citation>
<scope>CHARACTERIZATION OF ANGIOSTATIN</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1998" name="Biochemistry" volume="37" first="4699" last="4702">
<title>Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3).</title>
<authorList>
<person name="Lijnen H.R."/>
<person name="Ugwu F."/>
<person name="Bini A."/>
<person name="Collen D."/>
</authorList>
<dbReference type="PubMed" id="9548733"/>
<dbReference type="DOI" id="10.1021/bi9731798"/>
</citation>
<scope>PROTEOLYTIC CLEAVAGE</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="2811" last="2816">
<title>Angiostatin binds ATP synthase on the surface of human endothelial cells.</title>
<authorList>
<person name="Moser T.L."/>
<person name="Stack M.S."/>
<person name="Asplin I."/>
<person name="Enghild J.J."/>
<person name="Hojrup P."/>
<person name="Everitt L."/>
<person name="Hubchak S."/>
<person name="Schnaper H.W."/>
<person name="Pizzo S.V."/>
</authorList>
<dbReference type="PubMed" id="10077593"/>
<dbReference type="DOI" id="10.1073/pnas.96.6.2811"/>
</citation>
<scope>INTERACTION WITH ATP5A1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="28625" last="28633">
<title>Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen).</title>
<authorList>
<person name="Goretzki L."/>
<person name="Lombardo C.R."/>
<person name="Stallcup W.B."/>
</authorList>
<dbReference type="PubMed" id="10889192"/>
<dbReference type="DOI" id="10.1074/jbc.M002290200"/>
</citation>
<scope>INTERACTION WITH CSPG4</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="10346" last="10356">
<title>Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells.</title>
<authorList>
<person name="Rossignol P."/>
<person name="Ho-Tin-Noe B."/>
<person name="Vranckx R."/>
<person name="Bouton M.C."/>
<person name="Meilhac O."/>
<person name="Lijnen H.R."/>
<person name="Guillin M.C."/>
<person name="Michel J.B."/>
<person name="Angles-Cano E."/>
</authorList>
<dbReference type="PubMed" id="14699093"/>
<dbReference type="DOI" id="10.1074/jbc.M310964200"/>
</citation>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>ENZYME REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION OF PLASMIN</scope>
<scope>MUTAGENESIS OF SER-741</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="20993" last="20998">
<title>Cell surface adenosine deaminase binds and stimulates plasminogen activation on 1-LN human prostate cancer cells.</title>
<authorList>
<person name="Gonzalez-Gronow M."/>
<person name="Hershfield M.S."/>
<person name="Arredondo-Vega F.X."/>
<person name="Pizzo S.V."/>
</authorList>
<dbReference type="PubMed" id="15016824"/>
<dbReference type="DOI" id="10.1074/jbc.M401023200"/>
</citation>
<scope>INTERACTION WITH ADA</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="34859" last="34869">
<title>Angiomotin regulates endothelial cell-cell junctions and cell motility.</title>
<authorList>
<person name="Bratt A."/>
<person name="Birot O."/>
<person name="Sinha I."/>
<person name="Veitonmaeki N."/>
<person name="Aase K."/>
<person name="Ernkvist M."/>
<person name="Holmgren L."/>
</authorList>
<dbReference type="PubMed" id="16043488"/>
<dbReference type="DOI" id="10.1074/jbc.M503915200"/>
</citation>
<scope>INTERACTION WITH AMOT</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Proteomics" volume="8" first="3833" last="3847">
<title>Identification of N-linked glycoproteins in human milk by hydrophilic interaction liquid chromatography and mass spectrometry.</title>
<authorList>
<person name="Picariello G."/>
<person name="Ferranti P."/>
<person name="Mamone G."/>
<person name="Roepstorff P."/>
<person name="Addeo F."/>
</authorList>
<dbReference type="PubMed" id="18780401"/>
<dbReference type="DOI" id="10.1002/pmic.200701057"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-308</scope>
<source>
<tissue>Milk</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="13669" last="13676">
<title>A unique proteolytic fragment of human fibrinogen containing the A alpha COOH-terminal domain of the native molecule.</title>
<authorList>
<person name="Kirschbaum N.E."/>
<person name="Budzynski A.Z."/>
</authorList>
<dbReference type="PubMed" id="2143188"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="Biochem. J." volume="424" first="27" last="37">
<title>Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage.</title>
<authorList>
<person name="Poon I.K."/>
<person name="Olsson A.K."/>
<person name="Hulett M.D."/>
<person name="Parish C.R."/>
</authorList>
<dbReference type="PubMed" id="19712047"/>
<dbReference type="DOI" id="10.1042/BJ20090794"/>
</citation>
<scope>INTERACTION WITH HRG</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-688</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="1991" name="Biochemistry" volume="30" first="10576" last="10588">
<title>Crystal and molecular structure of human plasminogen kringle 4 refined at 1.9-A resolution.</title>
<authorList>
<person name="Mulichak A.M."/>
<person name="Tulinsky A."/>
<person name="Ravichandran K.G."/>
</authorList>
<dbReference type="PubMed" id="1657148"/>
<dbReference type="DOI" id="10.1021/bi00107a029"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 374-461</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1991" name="Biochemistry" volume="30" first="10589" last="10594">
<title>The refined structure of the epsilon-aminocaproic acid complex of human plasminogen kringle 4.</title>
<authorList>
<person name="Wu T.-P."/>
<person name="Padmanabhan K."/>
<person name="Tulinsky A."/>
<person name="Mulichak A.M."/>
</authorList>
<dbReference type="PubMed" id="1657149"/>
<dbReference type="DOI" id="10.1021/bi00107a030"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 374-461</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1994" name="Blood Coagul. Fibrinolysis" volume="5" first="157" last="166">
<title>The structure of recombinant plasminogen kringle 1 and the fibrin binding site.</title>
<authorList>
<person name="Wu T.-P."/>
<person name="Padmanabhan K.P."/>
<person name="Tulinsky A."/>
</authorList>
<dbReference type="PubMed" id="8054447"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.48 ANGSTROMS) OF 101-181</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1996" name="Biochemistry" volume="35" first="2567" last="2576">
<title>Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid.</title>
<authorList>
<person name="Mathews I.I."/>
<person name="Vanderhoff-Hanaver P."/>
<person name="Castellino F.J."/>
<person name="Tulinsky A."/>
</authorList>
<dbReference type="PubMed" id="8611560"/>
<dbReference type="DOI" id="10.1021/bi9521351"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 102-181</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1997" name="Acta Crystallogr. D" volume="53" first="169" last="178">
<title>Structure of human plasminogen kringle 4 at 1.68 Angstrom and 277 K. A possible structural role of disordered residues.</title>
<authorList>
<person name="Stec B."/>
<person name="Yamano A."/>
<person name="Whitlow M."/>
<person name="Teeter M.M."/>
</authorList>
<dbReference type="PubMed" id="15299951"/>
<dbReference type="DOI" id="10.1107/S0907444996012267"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.67 ANGSTROMS) OF 376-454</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1998" name="Nat. Struct. Biol." volume="5" first="917" last="923">
<title>The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action.</title>
<authorList>
<person name="Parry M.A."/>
<person name="Fernandez-Catalan C."/>
<person name="Bergner A."/>
<person name="Huber R."/>
<person name="Hopfner K.P."/>
<person name="Schlott B."/>
<person name="Guehrs K.H."/>
<person name="Bode W."/>
</authorList>
<dbReference type="PubMed" id="9783753"/>
<dbReference type="DOI" id="10.1038/2359"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 561-810</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1998" name="Biochemistry" volume="37" first="3258" last="3271">
<title>Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen.</title>
<authorList>
<person name="Chang Y."/>
<person name="Mochalkin I."/>
<person name="McCance S.G."/>
<person name="Cheng B."/>
<person name="Tulinsky A."/>
<person name="Castellino F.J."/>
</authorList>
<dbReference type="PubMed" id="9521645"/>
<dbReference type="DOI" id="10.1021/bi972284e"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.66 ANGSTROMS) OF 480-563</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2000" name="J. Mol. Biol." volume="295" first="903" last="914">
<title>Human plasminogen catalytic domain undergoes an unusual conformational change upon activation.</title>
<authorList>
<person name="Wang X."/>
<person name="Terzyan S."/>
<person name="Tang J."/>
<person name="Loy J.A."/>
<person name="Lin X."/>
<person name="Zhang X.C."/>
</authorList>
<dbReference type="PubMed" id="10656799"/>
<dbReference type="DOI" id="10.1006/jmbi.1999.3397"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 564-810</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2001" name="J. Mol. Biol." volume="308" first="705" last="719">
<title>Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.</title>
<authorList>
<person name="Rios-Steiner J.L."/>
<person name="Schenone M."/>
<person name="Mochalkin I."/>
<person name="Tulinsky A."/>
<person name="Castellino F.J."/>
</authorList>
<dbReference type="PubMed" id="11350170"/>
<dbReference type="DOI" id="10.1006/jmbi.2001.4646"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 183-262</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2002" name="J. Mol. Biol." volume="318" first="1009" last="1017">
<title>The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin.</title>
<authorList>
<person name="Abad M.C."/>
<person name="Arni R.K."/>
<person name="Grella D.K."/>
<person name="Castellino F.J."/>
<person name="Tulinsky A."/>
<person name="Geiger J.H."/>
</authorList>
<dbReference type="PubMed" id="12054798"/>
<dbReference type="DOI" id="10.1016/S0022-2836(02)00211-5"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 100-352</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2002" name="Protein Eng." volume="15" first="753" last="761">
<title>Effects of deletion of streptokinase residues 48-59 on plasminogen activation.</title>
<authorList>
<person name="Wakeham N."/>
<person name="Terzyan S."/>
<person name="Zhai P."/>
<person name="Loy J.A."/>
<person name="Tang J."/>
<person name="Zhang X.C."/>
</authorList>
<dbReference type="PubMed" id="12456874"/>
<dbReference type="DOI" id="10.1093/protein/15.9.753"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 562-810</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2004" name="Proteins" volume="56" first="277" last="284">
<title>Characterization of Lys-698-to-Met substitution in human plasminogen catalytic domain.</title>
<authorList>
<person name="Terzyan S."/>
<person name="Wakeham N."/>
<person name="Zhai P."/>
<person name="Rodgers K."/>
<person name="Zhang X.C."/>
</authorList>
<dbReference type="PubMed" id="15211511"/>
<dbReference type="DOI" id="10.1002/prot.20070"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 564-810</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E54104" last="E54104">
<title>The structure of human microplasmin in complex with textilinin-1, an aprotinin-like inhibitor from the Australian brown snake.</title>
<authorList>
<person name="Millers E.K."/>
<person name="Johnson L.A."/>
<person name="Birrell G.W."/>
<person name="Masci P.P."/>
<person name="Lavin M.F."/>
<person name="de Jersey J."/>
<person name="Guddat L.W."/>
</authorList>
<dbReference type="PubMed" id="23335990"/>
<dbReference type="DOI" id="10.1371/journal.pone.0054104"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.78 ANGSTROMS) OF 564-810 IN COMPLEX WITH THE SNAKE VENOM PROTEASE INHIBITOR TEXTILININ-1</scope>
<scope>DISULFIDE BOND</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1990" name="J. Mol. Biol." volume="212" first="541" last="552">
<title>Solution structure of the kringle 4 domain from human plasminogen by 1H nuclear magnetic resonance spectroscopy and distance geometry.</title>
<authorList>
<person name="Atkinson R.A."/>
<person name="Williams R.J.P."/>
</authorList>
<dbReference type="PubMed" id="2157850"/>
<dbReference type="DOI" id="10.1016/0022-2836(90)90330-O"/>
</citation>
<scope>STRUCTURE BY NMR OF 374-461</scope>
</reference>
<reference key="47">
<citation type="journal article" date="1994" name="Eur. J. Biochem." volume="221" first="927" last="937">
<title>1H-NMR assignments and secondary structure of human plasminogen kringle 1.</title>
<authorList>
<person name="Rejante M.R."/>
<person name="Llinas M."/>
</authorList>
<dbReference type="PubMed" id="8181475"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1994.tb18808.x"/>
</citation>
<scope>STRUCTURE BY NMR OF 96-184</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1994" name="Eur. J. Biochem." volume="221" first="939" last="949">
<title>Solution structure of the epsilon-aminohexanoic acid complex of human plasminogen kringle 1.</title>
<authorList>
<person name="Rejante M.R."/>
<person name="Llinas M."/>
</authorList>
<dbReference type="PubMed" id="8181476"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1994.tb18809.x"/>
</citation>
<scope>STRUCTURE BY NMR OF 96-184</scope>
</reference>
<reference key="49">
<citation type="journal article" date="1996" name="Biochemistry" volume="35" first="2357" last="2364">
<title>Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains.</title>
<authorList>
<person name="Soehndel S."/>
<person name="Hu C.-K."/>
<person name="Marti D."/>
<person name="Affolter M."/>
<person name="Schaller J."/>
<person name="Llinas M."/>
<person name="Rickli E.E."/>
</authorList>
<dbReference type="PubMed" id="8652577"/>
<dbReference type="DOI" id="10.1021/bi9520949"/>
</citation>
<scope>STRUCTURE BY NMR OF 183-354</scope>
</reference>
<reference key="50">
<citation type="journal article" date="1997" name="Biochemistry" volume="36" first="11591" last="11604">
<title>Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.</title>
<authorList>
<person name="Marti D.N."/>
<person name="Hu C.K."/>
<person name="An S.S."/>
<person name="von Haller P."/>
<person name="Schaller J."/>
<person name="Llinas M."/>
</authorList>
<dbReference type="PubMed" id="9305949"/>
<dbReference type="DOI" id="10.1021/bi971316v"/>
</citation>
<scope>STRUCTURE BY NMR OF 183-263</scope>
</reference>
<reference key="51">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="115" last="119">
<title>Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis.</title>
<authorList>
<person name="Ichinose A."/>
<person name="Espling E.S."/>
<person name="Takamatsu J."/>
<person name="Saito H."/>
<person name="Shinmyozu K."/>
<person name="Maruyama I."/>
<person name="Petersen T.E."/>
<person name="Davie E.W."/>
</authorList>
<dbReference type="PubMed" id="1986355"/>
<dbReference type="DOI" id="10.1073/pnas.88.1.115"/>
</citation>
<scope>VARIANTS PLGD PHE-374 AND THR-620</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="2067" last="2067">
<authorList>
<person name="Ichinose A."/>
<person name="Espling E.S."/>
<person name="Takamatsu J."/>
<person name="Saito H."/>
<person name="Shinmyozu K."/>
<person name="Maruyama I."/>
<person name="Petersen T.E."/>
<person name="Davie E.W."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1993" name="Blood" volume="82" first="475" last="480">
<title>Congenital plasminogen deficiency caused by a Ser-572 to Pro mutation.</title>
<authorList>
<person name="Azuma H."/>
<person name="Uno Y."/>
<person name="Shigekiyo T."/>
<person name="Saito S."/>
</authorList>
<dbReference type="PubMed" id="8392398"/>
</citation>
<scope>VARIANT PLGD PRO-591</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1982" name="Proc. Natl. Acad. Sci. U.S.A." volume="79" first="6132" last="6136">
<title>Plasminogen Tochigi: inactive plasmin resulting from replacement of alanine-600 by threonine in the active site.</title>
<authorList>
<person name="Miyata T."/>
<person name="Iwanaga S."/>
<person name="Sakata Y."/>
<person name="Aoki N."/>
</authorList>
<dbReference type="PubMed" id="6216475"/>
<dbReference type="DOI" id="10.1073/pnas.79.20.6132"/>
</citation>
<scope>VARIANT PLGD THR-620</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1984" name="J. Biochem." volume="96" first="277" last="287">
<title>Plasminogens Tochigi II and Nagoya: two additional molecular defects with Ala-600-->Thr replacement found in plasmin light chain variants.</title>
<authorList>
<person name="Miyata T."/>
<person name="Iwanaga S."/>
<person name="Sakata Y."/>
<person name="Aoki N."/>
<person name="Takamatsu J."/>
<person name="Kamiya T."/>
</authorList>
<dbReference type="PubMed" id="6238949"/>
</citation>
<scope>VARIANT PLGD THR-620</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1992" name="Hum. Genet." volume="90" first="7" last="11">
<title>Plasminogen with type-I mutation is polymorphic in the Japanese population.</title>
<authorList>
<person name="Kikuchi S."/>
<person name="Yamanouchi Y."/>
<person name="Li L."/>
<person name="Kobayashi K."/>
<person name="Ijima H."/>
<person name="Miyazaki R."/>
<person name="Tsuchiya S."/>
<person name="Hamaguchi H."/>
</authorList>
<dbReference type="PubMed" id="1427790"/>
<dbReference type="DOI" id="10.1007/BF00210737"/>
</citation>
<scope>VARIANT PLGD THR-620</scope>
</reference>
<reference key="57">
<citation type="journal article" date="1997" name="Blood" volume="90" first="958" last="966">
<title>Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis.</title>
<authorList>
<person name="Schuster V."/>
<person name="Mingers A.-M."/>
<person name="Seidenspinner S."/>
<person name="Nuessgens Z."/>
<person name="Pukrop T."/>
<person name="Kreth H.W."/>
</authorList>
<dbReference type="PubMed" id="9242524"/>
</citation>
<scope>VARIANT PLGD HIS-235</scope>
</reference>
<reference key="58">
<citation type="journal article" date="1998" name="Br. J. Haematol." volume="103" first="867" last="870">
<title>Plasminogen Kanagawa-I, a novel missense mutation, is caused by the amino acid substitution G732R.</title>
<authorList>
<person name="Higuchi Y."/>
<person name="Furihata K."/>
<person name="Ueno I."/>
<person name="Ishikawa S."/>
<person name="Okumura N."/>
<person name="Tozuka M."/>
<person name="Sakurai N."/>
</authorList>
<dbReference type="PubMed" id="9858247"/>
<dbReference type="DOI" id="10.1046/j.1365-2141.1998.01074.x"/>
</citation>
<scope>VARIANT PLGD ARG-751</scope>
</reference>
<reference key="59">
<citation type="journal article" date="1999" name="Blood" volume="93" first="3457" last="3466">
<title>Compound-heterozygous mutations in the plasminogen gene predispose to the development of ligneous conjunctivitis.</title>
<authorList>
<person name="Schuster V."/>
<person name="Seidenspinner S."/>
<person name="Zeitler P."/>
<person name="Escher C."/>
<person name="Pleyer U."/>
<person name="Bernauer W."/>
<person name="Stiehm E.R."/>
<person name="Isenberg S."/>
<person name="Seregard S."/>
<person name="Olsson T."/>
<person name="Mingers A.-M."/>
<person name="Schambeck C."/>
<person name="Kreth H.W."/>
</authorList>
<dbReference type="PubMed" id="10233898"/>
</citation>
<scope>VARIANTS PLGD GLU-38; PRO-147 AND HIS-532</scope>
</reference>
<comment type="function">
<text evidence="29">Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invasion may be modulated by CSPG4. Binds to cells.</text>
</comment>
<comment type="function">
<text evidence="29">Angiostatin is an angiogenesis inhibitor that blocks neovascularization and growth of experimental primary and metastatic tumors in vivo.</text>
</comment>
<comment type="catalytic activity">
<text evidence="36">Preferential cleavage: Lys-|-Xaa > Arg-|-Xaa; higher selectivity than trypsin. Converts fibrin into soluble products.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="29">Converted into plasmin by plasminogen activators, both plasminogen and its activator being bound to fibrin. Activated with catalytic amounts of streptokinase. Plasmin activity inhibited by SERPINE2.</text>
</comment>
<comment type="subunit">
<text evidence="24 26 30 32 34 43">Interacts (both mature PLG and the angiostatin peptide) with CSPG4 and AMOT (PubMed:10889192, PubMed:16043488). Interacts (via the Kringle domains) with HRG; the interaction tethers PLG to the cell surface and enhances its activation (PubMed:9102401, PubMed:19712047). Interacts (via Kringle 4 domain) with ADA; the interaction stimulates PLG activation when in complex with DPP4 (PubMed:15016824). Angiostatin: Interacts with ATP5A1; the interaction inhibits most of the angiogenic effects of angiostatin (PubMed:10077593).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-999394"/>
<interactant intactId="EBI-984250">
<id>Q6V4L1</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-999394"/>
<interactant intactId="EBI-984286">
<id>Q6V4L4</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-999394"/>
<interactant intactId="EBI-984118">
<id>Q6V4L5</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-999394"/>
<interactant intactId="EBI-984197">
<id>Q6V4L9</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-999394"/>
<interactant intactId="EBI-2114682">
<id>P02749</id>
<label>APOH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-999394"/>
<interactant intactId="EBI-2259629">
<id>P75390</id>
<label>pdhA</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-999394"/>
<interactant intactId="EBI-2259621">
<id>P75391</id>
<label>pdhB</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-999394"/>
<interactant intactId="EBI-2259593">
<id>P75392</id>
<label>pdhC</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-999394"/>
<interactant intactId="EBI-2259617">
<id>P75393</id>
<label>pdhD</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-999394"/>
<interactant intactId="EBI-7689378">
<id>Q99SU7</id>
<label>sak</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-999394"/>
<interactant intactId="EBI-1035089">
<id>P00779</id>
<label>skc</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="24 29">Secreted</location>
</subcellularLocation>
<text>Locates to the cell surface where it is proteolytically cleaved to produce the active plasmin. Interaction with HRG tethers it to the cell surface.</text>
</comment>
<comment type="tissue specificity">
<text>Present in plasma and many other extracellular fluids. It is synthesized in the liver.</text>
</comment>
<comment type="domain">
<text evidence="26">Kringle domains mediate interaction with CSPG4.</text>
</comment>
<comment type="PTM">
<text evidence="33 38 42">N-linked glycan contains N-acetyllactosamine and sialic acid. O-linked glycans consist of Gal-GalNAc disaccharide modified with up to 2 sialic acid residues (microheterogeneity).</text>
</comment>
<comment type="PTM">
<text evidence="29 46">In the presence of the inhibitor, the activation involves only cleavage after Arg-580, yielding two chains held together by two disulfide bonds. In the absence of the inhibitor, the activation involves additionally the removal of the activation peptide.</text>
</comment>
<comment type="disease" evidence="25 28 35 39 40 41 45 47">
<disease id="DI-02666">
<name>Plasminogen deficiency</name>
<acronym>PLGD</acronym>
<description>A disorder characterized by decreased serum plasminogen activity. Two forms of the disorder are distinguished: type 1 deficiency is additionally characterized by decreased plasminogen antigen levels and clinical symptoms, whereas type 2 deficiency, also known as dysplasminogenemia, is characterized by normal, or slightly reduced antigen levels, and absence of clinical manifestations. Plasminogen deficiency type 1 results in markedly impaired extracellular fibrinolysis and chronic mucosal pseudomembranous lesions due to subepithelial fibrin deposition and inflammation. The most common clinical manifestation of type 1 deficiency is ligneous conjunctivitis in which pseudomembranes formation on the palpebral surfaces of the eye progresses to white, yellow-white, or red thick masses with a wood-like consistency that replace the normal mucosa.</description>
<dbReference type="MIM" id="217090"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Plasmin is inactivated by alpha-2-antiplasmin immediately after dissociation from the clot.</text>
</comment>
<comment type="similarity">
<text evidence="22">Belongs to the peptidase S1 family. Plasminogen subfamily.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Plasmin"/>
<text>Plasmin entry</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/plg/"/>
</comment>
<dbReference type="EC" id="3.4.21.7"/>
<dbReference type="EMBL" id="M34276">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33272">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33274">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33275">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33278">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33279">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33280">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33282">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33283">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33284">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33285">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33286">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33287">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33288">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33289">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M33290">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M34272">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M34273">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M34275">
<property type="protein sequence ID" value="AAA60113.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X05199">
<property type="protein sequence ID" value="CAA28831.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M74220">
<property type="protein sequence ID" value="AAA36451.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY192161">
<property type="protein sequence ID" value="AAN85555.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL109933">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC060513">
<property type="protein sequence ID" value="AAH60513.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="K02922">
<property type="protein sequence ID" value="AAA60124.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5279.1"/>
<dbReference type="PIR" id="A35229">
<property type="entry name" value="PLHU"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000292.1">
<property type="nucleotide sequence ID" value="NM_000301.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.143436"/>
<dbReference type="PDB" id="1B2I">
<property type="method" value="NMR"/>
<property type="chains" value="A=181-263"/>
</dbReference>
<dbReference type="PDB" id="1BML">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=561-810"/>
</dbReference>
<dbReference type="PDB" id="1BUI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A/B=561-810"/>
</dbReference>
<dbReference type="PDB" id="1CEA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.06"/>
<property type="chains" value="A/B=100-187"/>
</dbReference>
<dbReference type="PDB" id="1CEB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.07"/>
<property type="chains" value="A/B=100-187"/>
</dbReference>
<dbReference type="PDB" id="1DDJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B/C/D=564-810"/>
</dbReference>
<dbReference type="PDB" id="1HPJ">
<property type="method" value="NMR"/>
<property type="chains" value="A=103-181"/>
</dbReference>
<dbReference type="PDB" id="1HPK">
<property type="method" value="NMR"/>
<property type="chains" value="A=103-181"/>
</dbReference>
<dbReference type="PDB" id="1I5K">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=184-262"/>
</dbReference>
<dbReference type="PDB" id="1KI0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=100-352"/>
</dbReference>
<dbReference type="PDB" id="1KRN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.67"/>
<property type="chains" value="A=374-461"/>
</dbReference>
<dbReference type="PDB" id="1L4D">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=562-810"/>
</dbReference>
<dbReference type="PDB" id="1L4Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=563-810"/>
</dbReference>
<dbReference type="PDB" id="1PK4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=376-454"/>
</dbReference>
<dbReference type="PDB" id="1PKR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.48"/>
<property type="chains" value="A=101-181"/>
</dbReference>
<dbReference type="PDB" id="1PMK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/B=374-461"/>
</dbReference>
<dbReference type="PDB" id="1QRZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B/C/D=565-810"/>
</dbReference>
<dbReference type="PDB" id="1RJX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="B=564-810"/>
</dbReference>
<dbReference type="PDB" id="2DOH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="X=100-333"/>
</dbReference>
<dbReference type="PDB" id="2DOI">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/X=100-333"/>
</dbReference>
<dbReference type="PDB" id="2KNF">
<property type="method" value="NMR"/>
<property type="chains" value="A=480-562"/>
</dbReference>
<dbReference type="PDB" id="2L0S">
<property type="method" value="NMR"/>
<property type="chains" value="A=272-354"/>
</dbReference>
<dbReference type="PDB" id="2PK4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=375-454"/>
</dbReference>
<dbReference type="PDB" id="3UIR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.78"/>
<property type="chains" value="A/B=564-810"/>
</dbReference>
<dbReference type="PDB" id="4A5T">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.49"/>
<property type="chains" value="S=20-810"/>
</dbReference>
<dbReference type="PDB" id="4CIK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.78"/>
<property type="chains" value="A=101-181"/>
</dbReference>
<dbReference type="PDB" id="4DCB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="F=576-585"/>
</dbReference>
<dbReference type="PDB" id="4DUR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A/B=20-810"/>
</dbReference>
<dbReference type="PDB" id="4DUU">
<property type="method" value="X-ray"/>
<property type="resolution" value="5.20"/>
<property type="chains" value="A=20-810"/>
</dbReference>
<dbReference type="PDB" id="5HPG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.66"/>
<property type="chains" value="A/B=480-563"/>
</dbReference>
<dbReference type="PDB" id="5UGD">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.38"/>
<property type="chains" value="A=562-810"/>
</dbReference>
<dbReference type="PDB" id="5UGG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.20"/>
<property type="chains" value="A=562-810"/>
</dbReference>
<dbReference type="PDBsum" id="1B2I"/>
<dbReference type="PDBsum" id="1BML"/>
<dbReference type="PDBsum" id="1BUI"/>
<dbReference type="PDBsum" id="1CEA"/>
<dbReference type="PDBsum" id="1CEB"/>
<dbReference type="PDBsum" id="1DDJ"/>
<dbReference type="PDBsum" id="1HPJ"/>
<dbReference type="PDBsum" id="1HPK"/>
<dbReference type="PDBsum" id="1I5K"/>
<dbReference type="PDBsum" id="1KI0"/>
<dbReference type="PDBsum" id="1KRN"/>
<dbReference type="PDBsum" id="1L4D"/>
<dbReference type="PDBsum" id="1L4Z"/>
<dbReference type="PDBsum" id="1PK4"/>
<dbReference type="PDBsum" id="1PKR"/>
<dbReference type="PDBsum" id="1PMK"/>
<dbReference type="PDBsum" id="1QRZ"/>
<dbReference type="PDBsum" id="1RJX"/>
<dbReference type="PDBsum" id="2DOH"/>
<dbReference type="PDBsum" id="2DOI"/>
<dbReference type="PDBsum" id="2KNF"/>
<dbReference type="PDBsum" id="2L0S"/>
<dbReference type="PDBsum" id="2PK4"/>
<dbReference type="PDBsum" id="3UIR"/>
<dbReference type="PDBsum" id="4A5T"/>
<dbReference type="PDBsum" id="4CIK"/>
<dbReference type="PDBsum" id="4DCB"/>
<dbReference type="PDBsum" id="4DUR"/>
<dbReference type="PDBsum" id="4DUU"/>
<dbReference type="PDBsum" id="5HPG"/>
<dbReference type="PDBsum" id="5UGD"/>
<dbReference type="PDBsum" id="5UGG"/>
<dbReference type="DisProt" id="DP00191"/>
<dbReference type="ProteinModelPortal" id="P00747"/>
<dbReference type="SMR" id="P00747"/>
<dbReference type="BioGrid" id="111356">
<property type="interactions" value="38"/>
</dbReference>
<dbReference type="IntAct" id="P00747">
<property type="interactions" value="42"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000308938"/>
<dbReference type="BindingDB" id="P00747"/>
<dbReference type="ChEMBL" id="CHEMBL1801"/>
<dbReference type="DrugBank" id="DB00009">
<property type="generic name" value="Alteplase"/>
</dbReference>
<dbReference type="DrugBank" id="DB00513">
<property type="generic name" value="Aminocaproic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00029">
<property type="generic name" value="Anistreplase"/>
</dbReference>
<dbReference type="DrugBank" id="DB06692">
<property type="generic name" value="Aprotinin"/>
</dbReference>
<dbReference type="DrugBank" id="DB03709">
<property type="generic name" value="Bicine"/>
</dbReference>
<dbReference type="DrugBank" id="DB04925">
<property type="generic name" value="Desmoteplase"/>
</dbReference>
<dbReference type="DrugBank" id="DB00015">
<property type="generic name" value="Reteplase"/>
</dbReference>
<dbReference type="DrugBank" id="DB00086">
<property type="generic name" value="Streptokinase"/>
</dbReference>
<dbReference type="DrugBank" id="DB00031">
<property type="generic name" value="Tenecteplase"/>
</dbReference>
<dbReference type="DrugBank" id="DB00302">
<property type="generic name" value="Tranexamic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00013">
<property type="generic name" value="Urokinase"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2394"/>
<dbReference type="MEROPS" id="S01.233"/>
<dbReference type="iPTMnet" id="P00747"/>
<dbReference type="PhosphoSitePlus" id="P00747"/>
<dbReference type="UniCarbKB" id="P00747"/>
<dbReference type="BioMuta" id="PLG"/>
<dbReference type="DMDM" id="130316"/>
<dbReference type="SWISS-2DPAGE" id="P00747"/>
<dbReference type="MaxQB" id="P00747"/>
<dbReference type="PaxDb" id="P00747"/>
<dbReference type="PeptideAtlas" id="P00747"/>
<dbReference type="PRIDE" id="P00747"/>
<dbReference type="Ensembl" id="ENST00000308192">
<property type="protein sequence ID" value="ENSP00000308938"/>
<property type="gene ID" value="ENSG00000122194"/>
</dbReference>
<dbReference type="GeneID" id="5340"/>
<dbReference type="KEGG" id="hsa:5340"/>
<dbReference type="UCSC" id="uc003qtm.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5340"/>
<dbReference type="DisGeNET" id="5340"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000122194.18"/>
<dbReference type="GeneCards" id="PLG"/>
<dbReference type="HGNC" id="HGNC:9071">
<property type="gene designation" value="PLG"/>
</dbReference>
<dbReference type="HPA" id="CAB000668"/>
<dbReference type="HPA" id="CAB016678"/>
<dbReference type="HPA" id="HPA021602"/>
<dbReference type="HPA" id="HPA048823"/>
<dbReference type="HPA" id="HPA053770"/>
<dbReference type="MalaCards" id="PLG"/>
<dbReference type="MIM" id="173350">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="217090">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P00747"/>
<dbReference type="OpenTargets" id="ENSG00000122194"/>
<dbReference type="Orphanet" id="722">
<property type="disease" value="Hypoplasminogenemia"/>
</dbReference>
<dbReference type="Orphanet" id="97231">
<property type="disease" value="Ligneous conjunctivitis"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33405"/>
<dbReference type="eggNOG" id="ENOG410IDXR">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5640">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119133"/>
<dbReference type="HOGENOM" id="HOG000112892"/>
<dbReference type="HOVERGEN" id="HBG004381"/>
<dbReference type="InParanoid" id="P00747"/>
<dbReference type="KO" id="K01315"/>
<dbReference type="OMA" id="PTYQCLK"/>
<dbReference type="OrthoDB" id="EOG091G0AH5"/>
<dbReference type="PhylomeDB" id="P00747"/>
<dbReference type="TreeFam" id="TF329901"/>
<dbReference type="BioCyc" id="MetaCyc:HS04553-MONOMER"/>
<dbReference type="BRENDA" id="3.4.21.7">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-114608">
<property type="pathway name" value="Platelet degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1474228">
<property type="pathway name" value="Degradation of the extracellular matrix"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1592389">
<property type="pathway name" value="Activation of Matrix Metalloproteinases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-186797">
<property type="pathway name" value="Signaling by PDGF"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381426">
<property type="pathway name" value="Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75205">
<property type="pathway name" value="Dissolution of Fibrin Clot"/>
</dbReference>
<dbReference type="SABIO-RK" id="P00747"/>
<dbReference type="SIGNOR" id="P00747"/>
<dbReference type="ChiTaRS" id="PLG">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P00747"/>
<dbReference type="GeneWiki" id="Plasmin"/>
<dbReference type="GeneWiki" id="Plasminogen_activator"/>
<dbReference type="GenomeRNAi" id="5340"/>
<dbReference type="PMAP-CutDB" id="P00747"/>
<dbReference type="PRO" id="PR:P00747"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 6"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000122194"/>
<dbReference type="CleanEx" id="HS_PLG"/>
<dbReference type="ExpressionAtlas" id="P00747">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P00747">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0072562">
<property type="term" value="C:blood microparticle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031232">
<property type="term" value="C:extrinsic component of external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044218">
<property type="term" value="C:other organism cell membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031093">
<property type="term" value="C:platelet alpha granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034185">
<property type="term" value="F:apolipoprotein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051087">
<property type="term" value="F:chaperone binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0004175">
<property type="term" value="F:endopeptidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:1904854">
<property type="term" value="F:proteasome core complex binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:1990405">
<property type="term" value="F:protein antigen binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0004252">
<property type="term" value="F:serine-type endopeptidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0008236">
<property type="term" value="F:serine-type peptidase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0007596">
<property type="term" value="P:blood coagulation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0022617">
<property type="term" value="P:extracellular matrix disassembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042730">
<property type="term" value="P:fibrinolysis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0051702">
<property type="term" value="P:interaction with symbiont"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0052213">
<property type="term" value="P:interaction with symbiont via secreted substance involved in symbiotic interaction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0052182">
<property type="term" value="P:modification by host of symbiont morphology or physiology via secreted substance"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:2000048">
<property type="term" value="P:negative regulation of cell-cell adhesion mediated by cadherin"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010812">
<property type="term" value="P:negative regulation of cell-substrate adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051918">
<property type="term" value="P:negative regulation of fibrinolysis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002576">
<property type="term" value="P:platelet degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043536">
<property type="term" value="P:positive regulation of blood vessel endothelial cell migration"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0051919">
<property type="term" value="P:positive regulation of fibrinolysis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0006508">
<property type="term" value="P:proteolysis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0048771">
<property type="term" value="P:tissue remodeling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd00190">
<property type="entry name" value="Tryp_SPc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000001">
<property type="entry name" value="Kringle"/>
</dbReference>
<dbReference type="InterPro" id="IPR013806">
<property type="entry name" value="Kringle-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR018056">
<property type="entry name" value="Kringle_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR003609">
<property type="entry name" value="Pan_app"/>
</dbReference>
<dbReference type="InterPro" id="IPR023317">
<property type="entry name" value="Pept_S1A_plasmin"/>
</dbReference>
<dbReference type="InterPro" id="IPR009003">
<property type="entry name" value="Peptidase_S1_PA"/>
</dbReference>
<dbReference type="InterPro" id="IPR001314">
<property type="entry name" value="Peptidase_S1A"/>
</dbReference>
<dbReference type="InterPro" id="IPR001254">
<property type="entry name" value="Trypsin_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR018114">
<property type="entry name" value="TRYPSIN_HIS"/>
</dbReference>
<dbReference type="InterPro" id="IPR033116">
<property type="entry name" value="TRYPSIN_SER"/>
</dbReference>
<dbReference type="Pfam" id="PF00051">
<property type="entry name" value="Kringle"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="Pfam" id="PF00024">
<property type="entry name" value="PAN_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00089">
<property type="entry name" value="Trypsin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF001150">
<property type="entry name" value="Plasmin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00722">
<property type="entry name" value="CHYMOTRYPSIN"/>
</dbReference>
<dbReference type="SMART" id="SM00130">
<property type="entry name" value="KR"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="SMART" id="SM00473">
<property type="entry name" value="PAN_AP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00020">
<property type="entry name" value="Tryp_SPc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50494">
<property type="entry name" value="SSF50494"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57440">
<property type="entry name" value="SSF57440"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="PROSITE" id="PS00021">
<property type="entry name" value="KRINGLE_1"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="PROSITE" id="PS50070">
<property type="entry name" value="KRINGLE_2"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="PROSITE" id="PS50948">
<property type="entry name" value="PAN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50240">
<property type="entry name" value="TRYPSIN_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00134">
<property type="entry name" value="TRYPSIN_HIS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00135">
<property type="entry name" value="TRYPSIN_SER"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0094">Blood coagulation</keyword>
<keyword id="KW-0165">Cleavage on pair of basic residues</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0280">Fibrinolysis</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0356">Hemostasis</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0420">Kringle</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0645">Protease</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0720">Serine protease</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0792">Thrombophilia</keyword>
<keyword id="KW-0797">Tissue remodeling</keyword>
<keyword id="KW-0865">Zymogen</keyword>
<feature type="signal peptide" evidence="27 49">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="chain" description="Plasminogen" id="PRO_0000028053">
<location>
<begin position="20"/>
<end position="810"/>
</location>
</feature>
<feature type="chain" description="Plasmin heavy chain A" id="PRO_0000028054">
<location>
<begin position="20"/>
<end position="580"/>
</location>
</feature>
<feature type="peptide" description="Activation peptide" id="PRO_0000028055">
<location>
<begin position="20"/>
<end position="97"/>
</location>
</feature>
<feature type="chain" description="Angiostatin" id="PRO_0000028057">
<location>
<begin position="79"/>
<end position="466"/>
</location>
</feature>
<feature type="chain" description="Plasmin heavy chain A, short form" id="PRO_0000028056">
<location>
<begin position="98"/>
<end position="580"/>
</location>
</feature>
<feature type="chain" description="Plasmin light chain B" id="PRO_0000028058">
<location>
<begin position="581"/>
<end position="810"/>
</location>
</feature>
<feature type="domain" description="PAN" evidence="23">
<location>
<begin position="20"/>
<end position="98"/>
</location>
</feature>
<feature type="domain" description="Kringle 1" evidence="21">
<location>
<begin position="103"/>
<end position="181"/>
</location>
</feature>
<feature type="domain" description="Kringle 2" evidence="21">
<location>
<begin position="184"/>
<end position="262"/>
</location>
</feature>
<feature type="domain" description="Kringle 3" evidence="21">
<location>
<begin position="275"/>
<end position="352"/>
</location>
</feature>
<feature type="domain" description="Kringle 4" evidence="21">
<location>
<begin position="377"/>
<end position="454"/>
</location>
</feature>
<feature type="domain" description="Kringle 5" evidence="21">
<location>
<begin position="481"/>
<end position="560"/>
</location>
</feature>
<feature type="domain" description="Peptidase S1" evidence="22">
<location>
<begin position="581"/>
<end position="808"/>
</location>
</feature>
<feature type="active site" description="Charge relay system">
<location>
<position position="622"/>
</location>
</feature>
<feature type="active site" description="Charge relay system">
<location>
<position position="665"/>
</location>
</feature>
<feature type="active site" description="Charge relay system">
<location>
<position position="760"/>
</location>
</feature>
<feature type="binding site" description="Fibrin">
<location>
<position position="134"/>
</location>
</feature>
<feature type="binding site" description="Fibrin">
<location>
<position position="136"/>
</location>
</feature>
<feature type="binding site" description="Omega-aminocarboxylic acids">
<location>
<position position="136"/>
</location>
</feature>
<feature type="binding site" description="Omega-aminocarboxylic acids">
<location>
<position position="158"/>
</location>
</feature>
<feature type="binding site" description="Omega-aminocarboxylic acids">
<location>
<position position="172"/>
</location>
</feature>
<feature type="binding site" description="Omega-aminocarboxylic acids">
<location>
<position position="432"/>
</location>
</feature>
<feature type="binding site" description="Omega-aminocarboxylic acids">
<location>
<position position="445"/>
</location>
</feature>
<feature type="site" description="Cleavage; by stromelysin-1">
<location>
<begin position="78"/>
<end position="79"/>
</location>
</feature>
<feature type="site" description="Cleavage; by stromelysin-19">
<location>
<begin position="466"/>
<end position="467"/>
</location>
</feature>
<feature type="site" description="Cleavage; by plasminogen activator">
<location>
<begin position="580"/>
<end position="581"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="44">
<location>
<position position="597"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="20">
<location>
<position position="688"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" id="CAR_000016" evidence="38 42">
<location>
<position position="268"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" id="CAR_000017" evidence="33 38">
<location>
<position position="308"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" id="CAR_000018" evidence="38">
<location>
<position position="365"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="49"/>
<end position="73"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="53"/>
<end position="61"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="103"/>
<end position="181"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="124"/>
<end position="164"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="152"/>
<end position="176"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="185"/>
<end position="262"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="188"/>
<end position="316"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="206"/>
<end position="245"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="234"/>
<end position="257"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="275"/>
<end position="352"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="296"/>
<end position="335"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="324"/>
<end position="347"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="377"/>
<end position="454"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="398"/>
<end position="437"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="426"/>
<end position="449"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="481"/>
<end position="560"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="502"/>
<end position="543"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="531"/>
<end position="555"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain (between A and B chains)">
<location>
<begin position="567"/>
<end position="685"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain (between A and B chains)">
<location>
<begin position="577"/>
<end position="585"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="607"/>
<end position="623"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="699"/>
<end position="766"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="729"/>
<end position="745"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="756"/>
<end position="784"/>
</location>
</feature>
<feature type="sequence variant" description="In PLGD; common mutation; dbSNP:rs73015965." id="VAR_018657" evidence="25">
<original>K</original>
<variation>E</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1049573." id="VAR_011779">
<original>I</original>
<variation>R</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4252070." id="VAR_016287" evidence="48">
<original>E</original>
<variation>K</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4252186." id="VAR_016288" evidence="48">
<original>H</original>
<variation>Q</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="sequence variant" description="In PLGD; dbSNP:rs770198253." id="VAR_018658" evidence="25">
<original>L</original>
<variation>P</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In PLGD; severe type 1 deficiency; dbSNP:rs121918030." id="VAR_018659" evidence="45">
<original>R</original>
<variation>H</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4252187." id="VAR_016289" evidence="48">
<original>R</original>
<variation>H</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In PLGD; Nagoya-1; dbSNP:rs121918028." id="VAR_006627" evidence="35">
<original>V</original>
<variation>F</variation>
<location>
<position position="374"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4252119." id="VAR_016290" evidence="48">
<original>R</original>
<variation>W</variation>
<location>
<position position="408"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1804181." id="VAR_011780">
<original>K</original>
<variation>I</variation>
<location>
<position position="453"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4252125." id="VAR_016291" evidence="37 48 49 50">
<original>D</original>
<variation>N</variation>
<location>
<position position="472"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4252128." id="VAR_016292" evidence="48">
<original>A</original>
<variation>V</variation>
<location>
<position position="494"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4252129." id="VAR_016293" evidence="48">
<original>R</original>
<variation>W</variation>
<location>
<position position="523"/>
</location>
</feature>
<feature type="sequence variant" description="In PLGD." id="VAR_018660" evidence="25">
<original>R</original>
<variation>H</variation>
<location>
<position position="532"/>
</location>
</feature>
<feature type="sequence variant" description="In PLGD; may be associated with susceptibility to thrombosis; dbSNP:rs121918029." id="VAR_006628" evidence="41">
<original>S</original>
<variation>P</variation>
<location>
<position position="591"/>
</location>
</feature>
<feature type="sequence variant" description="In PLGD; type 2 plasminogen deficiency; decreased activity; Nagoya-2/Tochigi/Kagoshima; may be associated with susceptibility to thrombosis; dbSNP:rs121918027." id="VAR_006629" evidence="28 35 39 40">
<original>A</original>
<variation>T</variation>
<location>
<position position="620"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17857492." id="VAR_031213" evidence="31">
<original>V</original>
<variation>D</variation>
<location>
<position position="676"/>
</location>
</feature>
<feature type="sequence variant" description="In PLGD; Kanagawa-1; 50% activity; dbSNP:rs121918033." id="VAR_006630" evidence="47">
<original>G</original>
<variation>R</variation>
<location>
<position position="751"/>
</location>
</feature>
<feature type="mutagenesis site" description="Proteolytically cleaved, but abolishes plasmin activity and cell detachment." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="741"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AA sequence." ref="8" evidence="51">
<original>A</original>
<variation>AQ</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AA sequence and 8; AA sequence." ref="7 8" evidence="51">
<original>Q</original>
<variation>E</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AA sequence and 8; AA sequence." ref="7 8" evidence="51">
<location>
<position position="86"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AA sequence and 9; AA sequence." ref="7 9" evidence="51">
<original>Q</original>
<variation>E</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA36451." ref="3" evidence="51">
<original>I</original>
<variation>V</variation>
<location>
<position position="701"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="25"/>
<end position="33"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="36"/>
<end position="42"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="46"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="57"/>
<end position="59"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="63"/>
<end position="67"/>
</location>
</feature>
<feature type="turn" evidence="17">
<location>
<begin position="68"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="72"/>
<end position="77"/>
</location>
</feature>
<feature type="turn" evidence="17">
<location>
<begin position="80"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="85"/>
<end position="96"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="97"/>
<end position="99"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="102"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="105"/>
<end position="110"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="113"/>
<end position="115"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="119"/>
<end position="121"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="131"/>
<end position="133"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="139"/>
<end position="141"/>
</location>
</feature>
<feature type="turn" evidence="16">
<location>
<begin position="143"/>
<end position="146"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="148"/>
<end position="150"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="155"/>
<end position="157"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="163"/>
<end position="167"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="172"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="180"/>
<end position="182"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="184"/>
<end position="186"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="205"/>
<end position="207"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="209"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="213"/>
<end position="215"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="221"/>
<end position="223"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="225"/>
<end position="227"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="237"/>
<end position="239"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="244"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="253"/>
<end position="256"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="273"/>
<end position="276"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="281"/>
<end position="283"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="291"/>
<end position="293"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="295"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="303"/>
<end position="305"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="311"/>
<end position="313"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="315"/>
<end position="317"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="334"/>
<end position="339"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="343"/>
<end position="346"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="377"/>
<end position="379"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="382"/>
<end position="384"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="405"/>
<end position="407"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="413"/>
<end position="415"/>
</location>
</feature>
<feature type="turn" evidence="15">
<location>
<begin position="417"/>
<end position="419"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="429"/>
<end position="431"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="436"/>
<end position="441"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="446"/>
<end position="450"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="460"/>
<end position="462"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="481"/>
<end position="483"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="487"/>
<end position="489"/>
</location>
</feature>
<feature type="strand" evidence="18">
<location>
<begin position="509"/>
<end position="511"/>
</location>
</feature>
<feature type="strand" evidence="18">
<location>
<begin position="514"/>
<end position="516"/>
</location>
</feature>
<feature type="turn" evidence="18">
<location>
<begin position="518"/>
<end position="520"/>
</location>
</feature>
<feature type="turn" evidence="17">
<location>
<begin position="522"/>
<end position="525"/>
</location>
</feature>
<feature type="strand" evidence="18">
<location>
<begin position="542"/>
<end position="546"/>
</location>
</feature>
<feature type="strand" evidence="18">
<location>
<begin position="552"/>
<end position="554"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="582"/>
<end position="586"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="595"/>
<end position="600"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="605"/>
<end position="613"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="616"/>
<end position="619"/>
</location>
</feature>
<feature type="helix" evidence="19">
<location>
<begin position="621"/>
<end position="623"/>
</location>
</feature>
<feature type="turn" evidence="19">
<location>
<begin position="624"/>
<end position="626"/>
</location>
</feature>
<feature type="helix" evidence="19">
<location>
<begin position="630"/>
<end position="632"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="633"/>
<end position="638"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="640"/>
<end position="644"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="650"/>
<end position="659"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="661"/>
<end position="663"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="667"/>
<end position="673"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="698"/>
<end position="704"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="708"/>
<end position="710"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="711"/>
<end position="714"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="717"/>
<end position="724"/>
</location>
</feature>
<feature type="helix" evidence="19">
<location>
<begin position="726"/>
<end position="729"/>
</location>
</feature>
<feature type="turn" evidence="19">
<location>
<begin position="732"/>
<end position="737"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="743"/>
<end position="746"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="749"/>
<end position="751"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="752"/>
<end position="754"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="763"/>
<end position="768"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="771"/>
<end position="780"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="782"/>
<end position="785"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="791"/>
<end position="795"/>
</location>
</feature>
<feature type="helix" evidence="19">
<location>
<begin position="796"/>
<end position="799"/>
</location>
</feature>
<feature type="helix" evidence="19">
<location>
<begin position="800"/>
<end position="809"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1B2I"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1BML"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1DDJ"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1HPJ"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1HPK"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1I5K"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1KI0"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1KRN"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1PK4"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1PMK"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1QRZ"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2DOH"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KNF"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2L0S"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2PK4"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4CIK"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4DUR"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5HPG"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UGG"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00121"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00274"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00315"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10077593"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10233898"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10889192"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="122932"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1427790"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14699093"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15016824"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16043488"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18780401"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19712047"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1986355"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2143188"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2318848"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3356193"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6216475"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6238949"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8392398"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9054441"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9102401"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9201958"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9242524"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9548733"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9858247"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="49" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="50" type="ECO:0000269">
<source ref="9"/>
</evidence>
<evidence key="51" type="ECO:0000305"/>
<sequence length="810" mass="90569" checksum="8B31CB877CCB3AB6" modified="1989-07-01" version="2" precursor="true">
MEHKEVVLLLLLFLKSGQGEPLDDYVNTQGASLFSVTKKQLGAGSIEECAAKCEEDEEFT
CRAFQYHSKEQQCVIMAENRKSSIIIRMRDVVLFEKKVYLSECKTGNGKNYRGTMSKTKN
GITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILE
CEEECMHCSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDRE
LRPWCFTTDPNKRWELCDIPRCTTPPPSSGPTYQCLKGTGENYRGNVAVTVSGHTCQHWS
AQTPHTHNRTPENFPCKNLDENYCRNPDGKRAPWCHTTNSQVRWEYCKIPSCDSSPVSTE
QLAPTAPPELTPVVQDCYHGDGQSYRGTSSTTTTGKKCQSWSSMTPHRHQKTPENYPNAG
LTMNYCRNPDADKGPWCFTTDPSVRWEYCNLKKCSGTEASVVAPPPVVLLPDVETPSEED
CMFGNGKGYRGKRATTVTGTPCQDWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDVGG
PWCYTTNPRKLYDYCDVPQCAAPSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRT
RFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLE
PTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQGTFGAGLLKEAQ
LPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSW
GLGCARPNKPGVYVRVSRFVTWIEGVMRNN
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>